These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37902432)

  • 1. Development and Validation of an MRI-Based Nomogram for Preoperative Detection of Muscle Invasion in VI-RADS 3.
    Yu R; Cai L; Cao Q; Liu P; Gong Y; Li K; Wu Q; Zhang Y; Li P; Yang X; Lu Q
    J Magn Reson Imaging; 2024 Aug; 60(2):448-457. PubMed ID: 37902432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2 Tumors With Stalk.
    Cai L; Yu R; Liu P; Zhuang J; Li K; Wu Q; Sun X; Liu Y; Zhou M; Cao Q; Li P; Yang X; Lu Q
    J Magn Reson Imaging; 2024 Apr; 59(4):1179-1190. PubMed ID: 37602726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting Muscle Invasion of Bladder Cancer: An Application of Diffusion Kurtosis Imaging Ratio and Vesical Imaging-Reporting and Data System.
    Qin C; Tian Q; Zhou H; Qin Y; Zhou S; Wu Y; Tianjiao E ; Duan S; Li Y; Wang X; Chen Z; Zheng G; Feng F
    J Magn Reson Imaging; 2024 Jul; 60(1):54-64. PubMed ID: 37916908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.
    Akcay A; Yagci AB; Celen S; Ozlulerden Y; Turk NS; Ufuk F
    Clin Imaging; 2021 Sep; 77():25-36. PubMed ID: 33639497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M; Farghaly S; Abdelkawi IF
    Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy.
    Wang X; Tu N; Sun F; Wen Z; Lan X; Lei Y; Cui E; Lin F
    J Magn Reson Imaging; 2021 Oct; 54(4):1212-1221. PubMed ID: 33998725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Arita Y; Shigeta K; Akita H; Suzuki T; Kufukihara R; Kwee TC; Ishii R; Mikami S; Okuda S; Kikuchi E; Oya M; Jinzaki M
    Eur Radiol; 2021 Feb; 31(2):875-883. PubMed ID: 32829418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer.
    Meng X; Hu H; Wang Y; Feng C; Hu D; Liu Z; Kamel IR; Li Z
    J Magn Reson Imaging; 2022 Aug; 56(2):391-398. PubMed ID: 35049074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Normalized Apparent Diffusion Coefficient in the Vesical Imaging-Reporting and Data System for Diagnosing Muscle-Invasive Bladder Cancer.
    Liu P; Cai L; Yu R; Cao Q; Bai K; Zhuang J; Wu Q; Li P; Yang X; Lu Q
    J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38153874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
    Ueno Y; Takeuchi M; Tamada T; Sofue K; Takahashi S; Kamishima Y; Hinata N; Harada K; Fujisawa M; Murakami T
    Eur Urol; 2019 Jul; 76(1):54-56. PubMed ID: 30922688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Sequence and Multi-Regional MRI-Based Radiomics Nomogram for the Preoperative Assessment of Muscle Invasion in Bladder Cancer.
    Zhang L; Li X; Yang L; Tang Y; Guo J; Li D; Li S; Li Y; Wang L; Lei Y; Qiao H; Yang G; Wang X
    J Magn Reson Imaging; 2023 Jul; 58(1):258-269. PubMed ID: 36300676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary Exploration of the Application of Vesical Imaging-Reporting and Data System (VI-RADS) in Post-treatment Patients With Bladder Cancer: A Prospective Single-Center Study.
    Cao B; Li Q; Xu P; Chen W; Hu X; Dai C; Shan Y; Ding Y; Mao W; Liu K; Wu PY; Sun W; Rao S; Zeng M; Jiang S; Zhou J
    J Magn Reson Imaging; 2022 Jan; 55(1):275-286. PubMed ID: 34184337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field.
    Watanabe M; Taguchi S; Machida H; Tambo M; Takeshita Y; Kariyasu T; Fukushima K; Shimizu Y; Okegawa T; Fukuhara H; Yokoyama K
    Eur Radiol; 2022 Nov; 32(11):7513-7521. PubMed ID: 35554648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating radiomics with the vesical imaging-reporting and data system to predict muscle invasion of bladder cancer.
    Wang W; Li W; Wang K; Wu J; Qiu J; Zhang Y; Zhang X; Wang H; Wang X
    Urol Oncol; 2023 Jun; 41(6):294.e1-294.e8. PubMed ID: 36526525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor.
    Kim SH
    Abdom Radiol (NY); 2020 Feb; 45(2):491-498. PubMed ID: 31422440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
    Xu X; Wang H; Du P; Zhang F; Li S; Zhang Z; Yuan J; Liang Z; Zhang X; Guo Y; Liu Y; Lu H
    J Magn Reson Imaging; 2019 Dec; 50(6):1893-1904. PubMed ID: 30980695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.